IL-6 was significantly increased in all infants from mothers with COVID-19 (19) and the clinical and immunological features suggested that both the concentration of IL-6 and TNF-α are higher in severe COVID-19 patients than in moderate patients (65). This evidence concerns the gene IL6 and COVID-19.